These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38272106)

  • 21. Clinical and Functional Genetic Characterization of the Role of Cardiac Calcium Channel Variants in the Early Repolarization Syndrome.
    Chen X; Barajas-Martínez H; Xia H; Zhang Z; Chen G; Yang B; Jiang H; Antzelevitch C; Hu D
    Front Cardiovasc Med; 2021; 8():680819. PubMed ID: 34222376
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes.
    Cordeiro JM; Nesterenko VV; Sicouri S; Goodrow RJ; Treat JA; Desai M; Wu Y; Doss MX; Antzelevitch C; Di Diego JM
    J Mol Cell Cardiol; 2013 Jul; 60():36-46. PubMed ID: 23542310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketanserin inhibits depolarization-activated outward potassium current in rat ventricular myocytes.
    Zhang ZH; Boutjdir M; el-Sherif N
    Circ Res; 1994 Oct; 75(4):711-21. PubMed ID: 7923617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Heterozygous Missense hERG Mutation Associated with Early Repolarization Syndrome.
    Cheng YJ; Yao H; Ji CC; Chen XM; Fan J; Liu LJ; Wu SH
    Cell Physiol Biochem; 2018; 51(3):1301-1312. PubMed ID: 30481776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin, a dietary natural supplement, prolongs the action potential duration of KCNE1-D85N-induced pluripotent stem cell-derived cardiomyocytes.
    Martinez K; Smith A; Ye D; Zhou W; Tester DJ; Ackerman MJ
    Heart Rhythm; 2023 Apr; 20(4):580-586. PubMed ID: 36586707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome.
    Mesquita FCP; Arantes PC; Kasai-Brunswick TH; Araujo DS; Gubert F; Monnerat G; Silva Dos Santos D; Neiman G; Leitão IC; Barbosa RAQ; Coutinho JL; Vaz IM; Dos Santos MN; Borgonovo T; Cruz FES; Miriuka S; Medei EH; Campos de Carvalho AC; Carvalho AB
    Sci Rep; 2019 Dec; 9(1):19203. PubMed ID: 31844156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injectable contraceptive Depo-Provera induces erratic beating patterns in patient-specific induced pluripotent stem cell-derived cardiomyocytes with long QT syndrome type 2.
    Pinsky AM; Gao X; Bains S; Kim CJ; Louradour J; Odening KE; Tester DJ; Giudicessi JR; Ackerman MJ
    Heart Rhythm; 2023 Jun; 20(6):910-917. PubMed ID: 36889623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
    Patocskai B; Barajas-Martinez H; Hu D; Gurabi Z; Koncz I; Antzelevitch C
    Heart Rhythm; 2016 Jun; 13(6):1326-34. PubMed ID: 26820510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.
    Kim M; Ye D; John Kim CS; Zhou W; Tester DJ; Giudicessi JR; Ackerman MJ
    Circ Genom Precis Med; 2021 Jun; 14(3):e003234. PubMed ID: 34003017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes.
    El-Battrawy I; Zhao Z; Lan H; Schünemann JD; Sattler K; Buljubasic F; Patocskai B; Li X; Yücel G; Lang S; Nowak D; Cyganek L; Bieback K; Utikal J; Zimmermann WH; Ravens U; Wieland T; Borggrefe M; Zhou XB; Akin I
    Int J Cardiol; 2018 Mar; 254():195-202. PubMed ID: 29407091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
    Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
    Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic mechanism of L-type calcium channel β-subunit downregulation in short QT human induced pluripotent stem cell-derived cardiomyocytes with CACNB2 mutation.
    Zhong R; Zhang F; Yang Z; Li Y; Xu Q; Lan H; Cyganek L; El-Battrawy I; Zhou X; Akin I; Borggrefe M
    Europace; 2022 Dec; 24(12):2028-2036. PubMed ID: 35894107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin Reduces Potassium Currents and Prolongs Repolarization in Non-Diabetic Heart.
    Malagueta-Vieira L; Fernández-Ruocco J; Hortigón-Vinagre MP; Zamora V; Zayas-Arrabal J; Echeazarra L; Smith GL; Vila Petroff M; Medei E; Casis Ó; Gallego M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Engineering of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cavanaugh C; Hesson J; Mathieu J
    Methods Mol Biol; 2024; 2735():129-143. PubMed ID: 38038847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
    Koncz I; Gurabi Z; Patocskai B; Panama BK; Szél T; Hu D; Barajas-Martínez H; Antzelevitch C
    J Mol Cell Cardiol; 2014 Mar; 68():20-8. PubMed ID: 24378566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies.
    Stutzman MJ; Gao X; Kim M; Ye D; Zhou W; Tester DJ; Giudicessi JR; Shannon K; Ackerman MJ
    Heart Rhythm; 2023 May; 20(5):709-717. PubMed ID: 36731785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.